International Journal of Pharma and Bio Sciences
 
 
    ISSN 0975-6299
www.ijpbs.net


REVIEW ARTICLE
Int J Pharm Bio Sci Volume 12 Issue 2, 2021 (April-June), Pages:33-41

A Review on the Emerging Epidemic of Novel Coronavirus (nCoV- SARS CoV-2): Present Combating Strategies

Dr. Diptendu Sarkar
DOI: http://dx.doi.org/10.22376/ijpbs.2021.12.2.b33-41
Abstract:

The COVID-19 pandemic has reached to a reached to that degree that it has broken down the entire world driving WHO to proclaim a "General Health Emergency of International Concern"on January 30, 2020. SARS-CoV-2 is closely related to the original SARS-CoV in terms of its pathogenicity, clinical range, and the study of disease transmission. Correlation of the genome groupings of COVID-19, SARS-CoV, and Middle East Respiratory Syndrome Covid (MERS-CoV) demonstrated that COVID-19 highlights a much better succession personality with SARS-CoV contrasted with MERS CoV. Patients have appeared to go through intense respiratory trouble disorder (ARDS), which is characterized as the cytokine storm. Be that as it may, drugs like favipiravir, remdesivir, chloroquine, and so forth have been demonstrated to be compelling for the treatment of the illness. According to the reports, a novel Covid, SARS-CoV-2 is causing the sickness and it utilizes the ACE2 catalysts that plays a counter-administrative impact on the traditional ACE ward pathway, as a receptor for its entrance inside the cell. An outline of the infection inside the cell is given in this review. It likewise recommends that analogues of ADAM-17 may be utilized as medicines for this infection and further exploration must be led to know the mechanism of the RAS framework. Studies propose that the human receptor for COVID-19 could likewise be angiotensin-changing over compound 2 (ACE2) receptor practically like that of SARS CoV. In this audit we will attempt to investigate the study of disease transmission, morphology, indications, transmission & conclusion. Moreover we attempt to give a review about this life threatening infection.

Keywords: nCOVID-19, Transmission, Virus, Host, RT-qPCR, Remdesivir, ADAM- 17
Full HTML:

Reference

1.       Taxonomy [internet]. International Committee on Taxonomy of Viruses (ICTV); 2020 [cited Nov 13 2020]. Available from: https://talk.ictvonline.org/taxonomy/.

2.       Ghinai I, McPherson TD, Hunter JC, Kirking HL, Christiansen D, Joshi K, Rubin R, Morales-Estrada S, Black SR, Pacilli M, Fricchione MJ, Chugh RK, Walblay KA, Ahmed NS, Stoecker WC, Hasan NF, Burdsall DP, Reese HE, Wallace M, Wang C, Moeller D, Korpics J, Novosad SA, Benowitz I, Jacobs MW, Dasari VS, Patel MT, Kauerauf J, Charles EM, Ezike NO, Chu V, Midgley CM, Rolfes MA, Gerber SI, Lu X, Lindstrom S, Verani JR, Layden JE, Illinois COVID-19 Investigation Team. First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA. Lancet. 2020;395(10230):1137-44. doi: 10.1016/S0140-6736(20)30607-3, PMID 32178768.

3.       Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, Akdis CA, Gao YD. Clinical characteristics of 140 patients infected with SARS?CoV?2 in Wuhan, China. Allergy. 2020;75(7):1730-41. doi: 10.1111/all.14238, PMID 32077115.

4.       Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, Xing X, Xiang N, Wu Y, Li C, Chen Q, Li D, Liu T, Zhao J, Liu M, Tu W, Chen C, Jin L, Yang R, Wang Q, Zhou S, Wang R, Liu H, Luo Y, Liu Y, Shao G, Li H, Tao Z, Yang Y, Deng Z, Liu B, Ma Z, Zhang Y, Shi G, Lam TTY, Wu JT, Gao GF, Cowling BJ, Yang B, Leung GM, Feng Z. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199-207. doi: 10.1056/NEJMoa2001316, PMID 31995857.

5.       Medical expert group of Tongji Hospital. Quick guide to the diagnosis and treatment of pneumonia for novel coronavirus infections. Herald Press Med; 2020. 3rd ed. Available from: http://kns.cnki.net/kcms/detail/42.1293.r.20200130.1803.002.html.

6.       Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, Xing X, Xiang N, Wu Y, Li C, Chen Q, Li D, Liu T, Zhao J, Liu M, Tu W, Chen C, Jin L, Yang R, Wang Q, Zhou S, Wang R, Liu H, Luo Y, Liu Y, Shao G, Li H, Tao Z, Yang Y, Deng Z, Liu B, Ma Z, Zhang Y, Shi G, Lam TTY, Wu JT, Gao GF, Cowling BJ, Yang B, Leung GM, Feng Z. Early transmission dynamics in Wuhan, China, of novel coronavirus- infected pneumonia. N Engl J Med. 2020;382(13):1199-207. doi: 10.1056/NEJMoa2001316, PMID 31995857.

7.       Liu Y, Gayle AA, Wilder-Smith A, Rocklöv J. The reproductive number of COVID-19 is higher compared to SARS coronavirus. J Travel Med. 2020;27(2). doi: 10.1093/jtm/taaa021, PMID 32052846.

8.       World Health Organization. Coronavirus disease (COVID-19) pandemic [cited 22/1/2021]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019.

9.       Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD, Chen J, Luo Y, Guo H, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao GF, Shi ZL. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270-3. doi: 10.1038/s41586-020-2012-7, PMID 32015507.

10.     Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, Hu Y, Tao ZW, Tian JH, Pei YY, Yuan ML, Zhang YL, Dai FH, Liu Y, Wang QM, Zheng JJ, Xu L, Holmes EC, Zhang YZ. Author Correction: A new coronavirus associated with human respiratory disease in China. Nature. 2020;580(7803):E7-. doi: 10.1038/s41586-020-2202-3, PMID 32296181.

11.     Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W, China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-33. doi: 10.1056/NEJMoa2001017, PMID 31978945.

12.     Wu F, Zhao S, Yu B, Chen Y, -M, Wang W et al. Complete genome characterisation of a novel coronavirus associated with severe human respiratory disease in Wuhan, China. bioRxiv. 2020.

13.     Wu F, Zhao S, Yu B, Chen YM, Wang W, Hu Y. Complete genome characterisation of a novel coronavirus associated with severe human respiratory disease in Wuhan, China. bioRxiv. 2020.

14.     Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, Zuo W. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. bioRxiv. 2020.

15.     Letko M, Munster V. Functional assessment of cell entry and receptor usage for lineage B β-coronaviruses, including 2019-nCoV. bioRxiv. 2020. doi: 10.1101/2020.01.22.915660, PMID 32511294.

16.     Dong N, Yang X, Ye L, Chen K, Chan EW, Yang M. Genomic and protein structure modelling analysis depicts the origin and infectivity of 2019-nCoV, a new coronavirus which caused a pneumonia outbreak in Wuhan, China. bioRxiv. 2020.

17.     Kumar S, Nyodu R, Maurya V, Saxena S. Morphology, genome Organization, Replication, and Pathogenesis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Medical virology: from pathogenesis to disease control. 2020;23-31.

18.     Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, Tan KS, Wang DY, Yan Y. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Mil Med Res. 2020;7(1):11. doi: 10.1186/s40779-020-00240-0, PMID 32169119.

19.     Xia S, Zhu Y, Liu M, Lan Q, Xu W, Wu Y, Ying T, Liu S, Shi Z, Jiang S, Lu L. Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein. Cell Mol Immunol. 2020;17(7):765-7. doi: 10.1038/s41423-020-0374-2, PMID 32047258.

20.     Yu F, Du L, Ojcius DM, Pan C, Jiang S. Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China. Microbes Infect. 2020;22(2):74-9. doi: 10.1016/j.micinf.2020.01.003, PMID 32017984.

21.     de Wilde AH, Snijder EJ, Kikkert M, van Hemert MJ. Hosts. Host Factors in Coronavirus Replication. Curr Top Microbiol Immunol. 2018;419:1-42. doi: 10.1007/82_2017_25. PMID 28643204.

22.     Sawicki SG, Sawicki DL. Coronavirus transcription: a perspective. Curr Top Microbiol Immunol. 2005;287:31-55. doi: 10.1007/3-540-26765-4_2, PMID 15609508.

23.     Hussain S, Pan J, Chen Y, Yang Y, Xu J, Peng Y, Wu Y, Li Z, Zhu Y, Tien P, Guo D. Identification of novel subgenomic RNAs and noncanonical transcription initiation signals of severe acute respiratory syndrome coronavirus. J Virol. 2005;79(9):5288-95. doi: 10.1128/JVI.79.9.5288-5295.2005, PMID 15827143.

24.     Perrier A, Bonnin A, Desmarets L, Danneels A, Goffard A, Rouillé Y, Dubuisson J, Belouzard S. The C-terminal domain of the MERS coronavirus M protein contains a trans-Golgi network localization signal. J Biol Chem. 2019;294(39):14406-21. doi: 10.1074/jbc.RA119.008964, PMID 31399512.

25.     Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: origin, transmission, and characteristics of human coronaviruses. J Adv Res. 2020;24:91-8. doi: 10.1016/j.jare.2020.03.005, PMID 32257431.

26.     Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631-7. doi: 10.1002/path.1570, PMID 15141377.

27.     Yadav T, Saxena S. Transmission cycle of SARS-CoV and SARS-CoV-2. Medical virology: from pathogenesis to disease control. 2020;33-42.

28.     Karakike E, Giamarellos-Bourboulis EJ. Macrophage activation-like syndrome: A distinct entity leading to early death in sepsis. Front Immunol. 2019;10:55. doi: 10.3389/fimmu.2019.00055, PMID 30766533.

29.     Eastin C, Eastin T. Clinical characteristics of coronavirus disease 2019 in China. Chin J Emerg Med. 2020;58(4):711-2. doi: 10.1016/j.jemermed.2020.04.004.

30.     Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus Disease 2019 (COVID-19) outbreak in China: summary of a Report of 72 314 Cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-42. doi: 10.1001/jama.2020.2648, PMID 32091533.

31.     Kumar S, Maurya VK, Prasad AK, Bhatt MLB, Saxena SK. Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV). VirusDisease. 2020;31(1):13-21. doi: 10.1007/s13337-020-00571-5, PMID 32206694.

32.     Li X, Geng M, Peng Y, Meng L, Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal. 2020;10(2):102-8. doi: 10.1016/j.jpha.2020.03.001, PMID 32282863.

33.     WHO. Novel coronavirus; 2019–. nCoV) situation reports; 2020b [cited Nov 13 2020]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports.

34.     WHO. Laboratory testing for 2019 novel coronavirus; 2019–. nCoV) in suspected human cases; 2020e [cited Nov 13 2020]. Available from: https://www.who.int/publications-detail/laboratory-testing-for-2019-novel-coronavirusin-suspected-human-cases-20200117.

35.     WHO. Guidelines for the safe transport of infectious substances and diagnostic specimens; 2020f. WHO.https://www.

36.     L Mk, FF. Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge, [Jm G. Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge]. Sci Transl Med. 2019;11(494).

37.     Gordon CJ, Tchesnokov EP, Feng JY, Porter DP, Götte M. The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus. J Biol Chem. 2020;295(15):4773-9. doi: 10.1074/jbc.AC120.013056, PMID 32094225.

38.        Patel VB, Clarke N, Wang Z, Fan D, Parajuli N, Basu R, Putko B, Kassiri Z, Turner AJ, Oudit GY. Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: a positive feedback mechanism in the RAS. J Mol Cell Cardiol. 2014 Jan 1;66:167-76. doi: 10.1016/j.yjmcc.2013.11.017, PMID 24332999

[Download PDF]
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy
Pharmaceutical Fields
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmaceutics
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Novel drug delivery system
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Nanotechnology
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmacology
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmacognosy
© Copyright 2009-2015 IJPBS, India. All rights reserved. Specialized online journals by ubijournal. Website by Ubitech Solutions
         Home I Contact I Terms & Conditions